Related Experiment Video

Updated: May 12, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

Management of inherited atherogenic dyslipidemias in children

Ornella Guardamagna1, Paola Cagliero, Francesca Abello

  • 1Department of Paediatrics, University of Torino, Torino, Italy. ornella.guardamagna@unito.it

Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
|April 5, 2013
PubMed

Insights

Early detection and management of inherited dyslipidemias in children are crucial for preventing cardiovascular disease. This review synthesizes current guidelines and highlights key aspects of screening and treatment for these genetic lipid disorders.

Area of Science:

  • Pediatrics
  • Cardiology
  • Genetics

Background:

  • Inherited dyslipidemias in childhood are an emerging concern for cardiovascular disease prevention.
  • Recent guidelines from the American Academy of Pediatrics and National Institute for Health and Clinical Excellence emphasize early detection.
  • Family history of genetic dyslipidemia or premature cardiovascular disease necessitates prompt evaluation.

Purpose of the Study:

  • To review and synthesize the literature on screening programs for inherited dyslipidemias in children.
  • To discuss the management strategies for atherogenic inherited dyslipidemias in pediatric populations.
  • To identify key cornerstones and criticisms in current diagnostic and therapeutic approaches.

Main Methods:

  • Literature synthesis and review of existing studies and guidelines.
  • Analysis of biochemical and genetic markers for lipoprotein disorders.
  • Evaluation of screening protocols and treatment outcomes.

Main Results:

  • A spectrum of inherited dyslipidemias can be identified using specific markers.
  • Early diagnosis is essential for initiating appropriate treatment and follow-up.
  • Guidelines provide a framework for managing these conditions in children and adolescents.

Conclusions:

  • Effective screening and management of childhood inherited dyslipidemias are vital for long-term cardiovascular health.
  • Continued research and critical evaluation of current practices are needed.
  • A comprehensive approach involving diagnosis, treatment, and follow-up is recommended.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...